AZN
AstraZeneca PLC
NASDAQ: AZN · HEALTHCARE · DRUG MANUFACTURERS - GENERAL
$187.37
+1.17% today
Updated 2026-04-30
Market cap
$294.17B
P/E ratio
28.97
P/S ratio
5.01x
EPS (TTM)
$6.55
Dividend yield
1.66%
52W range
$130 – $211
Volume
2.0M
AstraZeneca PLC (AZN) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $7.69B | $7.51B | $8.74B | $11.74B | $10.68B | $7.82B | $6.95B | $7.40B | $7.06B | $3.32B | $4.14B | $3.58B | $2.62B | $2.97B | $4.80B | $5.96B | $9.81B | $10.35B | $11.86B | $14.57B |
| Capital expenditures | $1.34B | $1.68B | $4.04B | $2.96B | $2.42B | $1.30B | $4.62B | $2.06B | $2.75B | $2.79B | $2.31B | $1.62B | $1.37B | $2.46B | $2.61B | $2.20B | $2.57B | $3.78B | $4.59B | $2.81B |
| Depreciation | $1.34B | $1.86B | $2.62B | $2.09B | $2.74B | $2.55B | $2.52B | $4.58B | $3.28B | $2.85B | $2.36B | $3.04B | $3.75B | $3.76B | $3.15B | $6.53B | $5.48B | $4.93B | $5.07B | $5.73B |
| Stock-based comp | — | — | — | — | — | — | — | — | — | — | — | — | — | $259.00M | $277.00M | $615.00M | $619.00M | $579.00M | — | — |
| Free cash flow | $6.35B | $5.83B | $4.70B | $8.78B | $8.26B | $6.52B | $2.33B | $5.34B | $4.31B | $536.00M | $1.83B | $1.96B | $1.25B | $509.00M | $2.19B | $3.76B | $7.24B | $6.57B | $7.28B | $11.77B |
| Investing cash flow | $-252.00M | $-10.76B | $-7.82B | $-2.48B | $-2.34B | $-2.02B | $-1.86B | $-2.89B | $-7.03B | $-4.24B | $-3.97B | $-2.33B | $963.00M | $-657.00M | $-285.00M | $-11.06B | $-2.96B | $-4.06B | $-7.98B | $-6.81B |
| Financing cash flow | $-5.39B | $1.93B | $-2.44B | $-3.63B | $-7.22B | $-9.32B | $-4.92B | $-3.05B | $-2.71B | $878.00M | $-1.32B | $-2.94B | $-2.04B | $-1.76B | $-2.20B | $3.65B | $-6.82B | $-6.57B | $-4.00B | $-7.54B |
| Dividends paid | $2.22B | $2.64B | $2.74B | $2.98B | $3.36B | $3.76B | $3.67B | $3.46B | $3.52B | $3.49B | $3.56B | $3.52B | $3.48B | $3.59B | $3.57B | $3.86B | $4.36B | $4.48B | $4.63B | $5.08B |
| Share repurchases | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |